首页 | 本学科首页   官方微博 | 高级检索  
     

淫羊藿治疗糖皮质激素性骨质疏松症分子机制的网络药理学分析
引用本文:许坤,庞坚,张洁帆,王用玉,赵咏芳,郭海玲. 淫羊藿治疗糖皮质激素性骨质疏松症分子机制的网络药理学分析[J]. 中国骨质疏松杂志, 2021, 0(4): 518-525
作者姓名:许坤  庞坚  张洁帆  王用玉  赵咏芳  郭海玲
作者单位:1.上海中医药大学附属曙光医院石氏伤科医学中心,上海 2001202.上海市中医药研究院骨伤科研究所,上海 200120
基金项目:国家自然科学基金项目(81674003,81774342,81473703);上海市进一步加快中医药事业发展三年行动计划(2018年-2020年)中医药传承创新平台建设[ZY(2018-2020)-CCCX-2003-05];上海市浦东新区卫生系统重点学科群“老年骨骼疾病防治”(PWZxq2014-10);上海申康医院发展中心慢性病综合防治项目(SHDC12015316);上海中医健康服务协同创新中心开放项目(ZYJKFW201811005); 上海市重中之重临床重点学科建设项目“中医骨伤科学”(2017ZZ02024)
摘    要:目的 利用网络药理学方法探索淫羊藿治疗糖皮质激素性骨质疏松症(glucocorticoid-induced osteoporosis,GIOP)的分子作用机制.方法 运用中药系统药理学数据库与分析平台(TCMSP)筛选淫羊藿的活性成分及相关靶点;运用GeneCards数据库、OMIM数据库获取GIOP的疾病靶点;通过R...

关 键 词:网络药理学  淫羊藿  糖皮质激素性骨质疏松症

Network pharmacology analysis of the molecular mechanism of herba epimedii in the treatment of glucocorticoid-induced osteoporosis
XU Kun,PANG Jian,ZHANG Jiefan,WANG Yongyu,ZHAO Yongfang,GUO Hailing. Network pharmacology analysis of the molecular mechanism of herba epimedii in the treatment of glucocorticoid-induced osteoporosis[J]. Chinese Journal of Osteoporosis, 2021, 0(4): 518-525
Authors:XU Kun  PANG Jian  ZHANG Jiefan  WANG Yongyu  ZHAO Yongfang  GUO Hailing
Abstract:Objective To explore the molecular mechanism of herba epimedii in the treatment of glucocorticoid-induced osteoporosis (GIOP) with network pharmacology. Methods The active ingredients and related targets of herba epimedii were screened with Traditional Chinese Medicine Systems Pharmacology Database and Analysis Platform (TCMSP). The disease target of GIOP was obtained with Used GeneCards database and OMIM database. The drug target was intersected with the GIOP disease target through R language. The Cytoscape 3.7.0 software was used to construct a network of herba epimedii-active ingredient-GIOP target. Herba epimedii-GIOP protein-protein interaction (PPI) network was constructed using the String database. The gene ontology (GO) biological function enrichment and Kyoto encyclopedia of genes and genomes (KEGG) pathway were analyzed using R language. Results Twenty-three major active ingredient of herba epimedii were obtained through the screening, and a total of 65 GIOP-related targets were involved. Quercetin, kaempferol, luteolin, and icariin connected with more than 10 related targets, which were the main components of epimedium in the treatment of GIOP. IL-6, VEGFA, MAPK8, CASP3, and ESR1 were the five most frequently linked targets in the interaction of common target protein of epimedium-GIOP, which were the core target genes. Conclusion Herba epimedii may have the treatment effect on GIOP through prostate cancer pathway, cell apoptosis pathway, fluid sheer stress and atherosclerosis pathway, TNF signal pathway, and AGE-RAGE signal pathway in diabetes. This provides a new thought and direction for the study of the mechanism of pharmacodynamics.
Keywords:network pharmacology   herba epimedii   glucocorticoid-induced osteoporosis
本文献已被 CNKI 等数据库收录!
点击此处可从《中国骨质疏松杂志》浏览原始摘要信息
点击此处可从《中国骨质疏松杂志》下载免费的PDF全文
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号